328
Views
8
CrossRef citations to date
0
Altmetric
Treatment

The effect of statins for asthma. A systematic review and meta-analysis

, md, , md, phd, , md, phd, , md, phd, , md, , md, phd & , md, phdORCID Icon show all
Pages 801-810 | Received 12 Nov 2020, Accepted 18 Jan 2021, Published online: 16 Feb 2021
 

Abstract

Objective:

To assess the effects of statins on asthma by systematically reviewing and conducting a meta-analysis on all clinical studies, including randomized controlled trials (RCTs) and observational studies, that examined the effects of statins on asthma.

Methods:

PubMed, EMBASE databases, and Cochrane reviews were searched to identify RCTs and observational studies, conducted through June 16, 2020, that assessed the effect of statins as a treatment for asthma. A meta-analysis was conducted using the following main outcomes: asthma control test (ACT), asthma control questionnaire (ACQ), pre- and post-bronchodilator forced expiratory volume in one second (FEV1), peak flow (PEF), and asthma exacerbation (asthma-related emergency department (ED) visits and hospitalization).

Results:

Our search revealed 11 RCTs and 8 observational studies that met the inclusion criteria. A meta-analysis demonstrated that statin treatment significantly improved ACT scores (mean difference: 1.61, P < 0.001) and ACQ scores (mean difference: −0.38, P < 0.001) compared to a placebo. Furthermore, statin treatment significantly reduced asthma-related ED visits (hazard ratio [HR], 95% confidence interval [CI], 0.83 [0.75–0.92], P < 0.001, number needed to treat [NNT], 5.9). However, statin treatment did not improve pulmonary function (FEV1 and PEF).

Conclusion:

Our results suggest that statins have the potential to improve asthma control and reduce asthma exacerbation without any improvement in pulmonary function.

Supplemental data for this article can be accessed at publisher’s website.

Acknowledgements

We thank all the members of the pulmonary division of Keio University School of Medicine.

Disclosure statement

HK received a research grant from GSK Japan. KF received honoraria from Boehringer Ingelheim and AstraZeneca. All other authors have no conflicts of interest to declare.

The authors alone are responsible for the content and writing of this article.

Additional information

Funding

This study was supported in part by JSPS KAKENHI, Grant Number: JP20K18193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.